NCT02454153View on ClinicalTrials.gov

Hyperglycemic Profiles in Obstructive Sleep Apnea: Effects of PAP Therapy

NACompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 15, 2020

Study Completion Date

March 15, 2020

Conditions
Sleep ApneaDiabetes
Interventions
DEVICE

REMStar Positive Airway Pressure

Positive airway pressure therapy is the standard of care for managing obstructive sleep apnea

BEHAVIORAL

LifeStyle Counseling

Lifestyle guidelines developed by the American Diabetes Association for weight loss will be provided to all subjects.

Trial Locations (1)

21224

Johns Hopkins Bayview Medical Center, Baltimore

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Johns Hopkins University

OTHER

NCT02454153 - Hyperglycemic Profiles in Obstructive Sleep Apnea: Effects of PAP Therapy | Biotech Hunter | Biotech Hunter